Yongke Zhang
CSO IASO Biotherapeutics
Dr. Yongke Zhang serves as the Chief Scientific Officer at IASO Bio with over 26 years of experience in the industry. His career includes roles at Merck Research Labs, AbbVie, Epitomics, Apexigen, AbCyte Therapeutics, and OBiO Tech in the USA, leading therapeutic antibody, CAR-T cell therapies, preclinical development, and clinical research. He holds a doctor’s degree in Internal Medicine, Clinical Medicine from the Health Science Center of Peking University and a doctor’s degree in Cell and Molecular Biology from the University of Tokyo.
